Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 762

1.

Patients with urticaria are at a higher risk of anaphylaxis: A nationwide population-based retrospective cohort study in Taiwan.

Yong SB, Chen HH, Huang JY, Wei JC.

J Dermatol. 2018 Jul 13. doi: 10.1111/1346-8138.14532. [Epub ahead of print]

PMID:
30004591
2.

Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: A case report.

Wang CR, Yang CC.

Medicine (Baltimore). 2018 Jun;97(25):e11053. doi: 10.1097/MD.0000000000011053.

3.

Presence of hepatitis B virus in synovium and its clinical significance in rheumatoid arthritis.

Chen YL, Jing J, Mo YQ, Ma JD, Yang LJ, Chen LF, Zhang X, Yan T, Zheng DH, Pessler F, Dai L.

Arthritis Res Ther. 2018 Jun 19;20(1):130. doi: 10.1186/s13075-018-1623-y.

4.

Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study.

Eun Y, Kim IY, Jeong H, Kim H, Lee J, Choi MS, Koh E, Cha HS.

J Korean Med Sci. 2018 May 10;33(23):e168. doi: 10.3346/jkms.2018.33.e168. eCollection 2018 Jun 4.

5.

Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan.

Fujita M, Sugiyama M, Sato Y, Nagashima K, Takahashi S, Mizokami M, Hata A.

J Viral Hepat. 2018 May 16. doi: 10.1111/jvh.12933. [Epub ahead of print]

PMID:
29770539
6.

Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study.

Chen YL, Lin JZ, Mo YQ, Ma JD, Li QH, Wang XY, Yang ZH, Yan T, Zheng DH, Dai L.

Arthritis Res Ther. 2018 May 2;20(1):81. doi: 10.1186/s13075-018-1548-5.

7.

Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.

Chiu YM, Lai MS, Chan KA.

PLoS One. 2018 Apr 25;13(4):e0196210. doi: 10.1371/journal.pone.0196210. eCollection 2018.

8.

Rheumatoid Arthritis: Common Questions About Diagnosis and Management.

Wasserman A.

Am Fam Physician. 2018 Apr 1;97(7):455-462.

PMID:
29671563
9.

XBP1 activation enhances MANF expression via binding to endoplasmic reticulum stress response elements within MANF promoter region in hepatitis B.

Wang D, Hou C, Cao Y, Cheng Q, Zhang L, Li H, Feng L, Shen Y.

Int J Biochem Cell Biol. 2018 Jun;99:140-146. doi: 10.1016/j.biocel.2018.04.007. Epub 2018 Apr 9.

PMID:
29649564
10.

Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.

Ahn SS, Jung SM, Song JJ, Park YB, Park JY, Lee SW.

Yonsei Med J. 2018 May;59(3):452-456. doi: 10.3349/ymj.2018.59.3.452.

11.

Late and Vague Presentation of Septic Arthritis of Hip in a IVDrug Abuser.

Raghupathi AK, Joshi A.

J Orthop Case Rep. 2017 Nov-Dec;7(6):13-15. doi: 10.13107/jocr.2250-0685.928.

12.

[Viral arthritis].

Zambaz C, Dan D.

Rev Med Suisse. 2018 Mar 7;14(597):526-528. French.

PMID:
29512949
13.

Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.

Bonanni A, Calatroni M, D'Alessandro M, Signa S, Bertelli E, Cioni M, Di Marco E, Biassoni R, Caridi G, Ingrasciotta G, Bertelli R, Di Donato A, Bruschi M, Canepa A, Piaggio G, Ravani P, Ghiggeri GM.

Br J Clin Pharmacol. 2018 Jun;84(6):1238-1249. doi: 10.1111/bcp.13548. Epub 2018 Mar 25.

PMID:
29436729
14.

Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management.

Cannizzaro MV, Franceschini C, Esposito M, Bianchi L, Giunta A.

Psoriasis (Auckl). 2017 Apr 15;7:35-40. doi: 10.2147/PTT.S108209. eCollection 2017. Review.

15.

Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs.

Meroni PL, Zavaglia D, Girmenia C.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):317-328. Epub 2017 Dec 15. Review.

16.

Hepatitis B virus reactivation in patients with rheumatoid arthritis: A single-center study.

Matsuzaki T, Eguchi K, Nagao N, Tsuji S, Aramaki T, Terada K, Iwatsu S, Tokimura I, Kamo Y, Oda H, Kinoshita N, Miyaaki H, Taura N, Ichikawa T, Kawakami A, Nakao K, Ueki Y.

Mod Rheumatol. 2018 Jan 22:1-6. doi: 10.1080/14397595.2017.1419842. [Epub ahead of print]

PMID:
29256314
18.

Biological therapy in arthritis patients with hepatitis B or C infection: a multicenter retrospective case series.

Abdulaziz S, Halabi H, Omair MA, Attar S, Alghamdi A, Shabrawishi M, Neyazi A, Alnazzawi H, Meraiani N, Almoallim H.

Eur J Rheumatol. 2017 Sep;4(3):194-199. doi: 10.5152/eurjrheum.2017.17003. Epub 2017 Sep 1.

19.

Risk-stratified management strategies for HBV reactivation in RA patients receiving biological and targeted therapy: A narrative review.

Chen YM, Yang SS, Chen DY.

J Microbiol Immunol Infect. 2017 Nov 5. pii: S1684-1182(17)30234-7. doi: 10.1016/j.jmii.2017.10.002. [Epub ahead of print] Review.

Supplemental Content

Loading ...
Support Center